From Regenerative Medicine to Immuno-Oncology,
From Autologous strategy to Allogeneic approach,
From primary cells to GMO cells
From Manufacturing Process, Analytics Bioassays, Quality Control Testing to Stability studies,
YOUR REQUIREMENTS ARE OUR PRIORITIES
Press
28.02.2022
The OPTI-STEM consortium led by Cell-Easy to democratize access to cell therapy in France and Europe
Toulouse, La Madeleine, Nancy, France – 28 February, 2022 The […]
Press
07.02.2022
Virginie Duel joins Cell-Easy as Head of Quality Control.
The Cell-Easy management team is very pleased to […]